Howe Jill Ann — SEC Form 4 filings

SEC reporting owner CIK 1892397. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-06.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-08 to 2026-03-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Lineage Cell Therapeutics, Inc. (LCTX)Chief Financial Officer52 legs · 25,500 sh · $18,1953
BIORA THERAPEUTICS, INC. (BIOR)Director12

Form 4 filings — Howe Jill Ann

FiledFormIssuerReported transactionsSource
2026-03-064Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 1,050,000 (derivative) @ $0EDGAR
2025-03-124Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 750,000 (derivative) @ $0EDGAR
2024-11-264Lineage Cell Therapeutics, Inc. (LCTX)Purchase (P): 15,000 @ $0.59EDGAR
2024-08-194Lineage Cell Therapeutics, Inc. (LCTX)Purchase (P): 10,500 @ $0.89EDGAR
2024-06-064BIORA THERAPEUTICS, INC. (BIOR)Grant/award (A): 12,500 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2024-03-084Lineage Cell Therapeutics, Inc. (LCTX)Grant/award (A): 650,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1892397 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →